(Q33333934)

25 July 2017

title

Prospective evaluation of oral mucositis in patients receiving myeloablative conditioning regimens and haemopoietic progenitor rescue (English)

1 reference

25 July 2017

0 references

1 reference

Wardley AM

1

1 reference

25 July 2017

Jayson GC

2

1 reference

25 July 2017

Swindell R

3

1 reference

25 July 2017

Morgenstern GR

4

1 reference

25 July 2017

Chang J

5

1 reference

25 July 2017

Bloor R

6

1 reference

25 July 2017

Fraser CJ

7

1 reference

25 July 2017

Scarffe JH

8

1 reference

25 July 2017

language of work or name

English

0 references

publication date

1 August 2000

1 reference

British Journal of Haematology

25 July 2017

published in

1 reference

25 July 2017

volume

110

1 reference

25 July 2017

issue

2

1 reference

25 July 2017

page(s)

292-299

1 reference

Double dose-intensive chemotherapy with autologous marrow and peripheral-blood progenitor-cell support for metastatic breast cancer: a feasibility study

25 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2000.02202.X

Toxicities of total-body irradiation for pediatric bone marrow transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2000.02202.X

Effect of granulocyte colony-stimulating factor on neutropenia and associated morbidity due to chemotherapy for transitional-cell carcinoma of the urothelium

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2000.02202.X

Use of granulocyte colony stimulating factor to reduce the toxicity of super-VAC chemotherapy in advanced solid tumours in childhood.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2000.02202.X

Randomized double-blind prospective trial to evaluate the effects of sargramostim versus placebo in a moderate-dose fluorouracil, doxorubicin, and cyclophosphamide adjuvant chemotherapy program for stage II and III breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2000.02202.X

Intensive melphalan chemotherapy and cryopreserved autologous bone marrow transplantation for the treatment of refractory cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2000.02202.X

Severe myelosuppression resulting from concurrent administration of granulocyte colony-stimulating factor and cytotoxic chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2000.02202.X

Reporting results of cancer treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2000.02202.X

The impact of mucositis on alpha-hemolytic streptococcal infection in patients undergoing autologous bone marrow transplantation for hematologic malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2000.02202.X

Clinical assessment scale for the rating of oral mucosal changes associated with bone marrow transplantation. Development of an oral mucositis index

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2000.02202.X

Oral complications in patients receiving treatment for malignancies other than of the head and neck

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2000.02202.X

The role of herpes simplex virus in the development of oral mucositis in bone marrow transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2000.02202.X

10.1046/J.1365-2141.2000.02202.X

21 January 2018

Identifiers

DOI

1 reference

25 July 2017

1 reference